While meta-analyses examining the relationship between RCC histology and irAE risk are scarce, some evidence suggests ccRCC may carry a higher irAE risk due to its immunogenic properties, driven by VHL gene alterations and VEGF signalling. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.